gefitinib has been researched along with 1,7-phenanthroline in 1 studies
| Studies (gefitinib) | Trials (gefitinib) | Recent Studies (post-2010) (gefitinib) | Studies (1,7-phenanthroline) | Trials (1,7-phenanthroline) | Recent Studies (post-2010) (1,7-phenanthroline) |
|---|---|---|---|---|---|
| 5,231 | 566 | 2,919 | 5,049 | 37 | 1,338 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Du, J; Kang, Y; Lin, Y; Luo, Q; Wang, F; Wang, Y; Wang, Z; Wu, K; Zhang, Y; Zhao, Y; Zheng, W | 1 |
1 other study(ies) available for gefitinib and 1,7-phenanthroline
| Article | Year |
|---|---|
Synthesis, Characterization, and in Vitro Antitumor Activity of Ruthenium(II) Polypyridyl Complexes Tethering EGFR-Inhibiting 4-Anilinoquinazolines.
Topics: 2,2'-Dipyridyl; Aniline Compounds; Antineoplastic Agents; Apoptosis; Benzimidazoles; Cell Line, Tumor; Cisplatin; Coordination Complexes; DNA; ErbB Receptors; Fluorescent Dyes; Gefitinib; Humans; Hydrolysis; Ligands; Membrane Proteins; Phenanthrolines; Quinazolines; Ruthenium | 2016 |